Overexpression of an Immune Checkpoint (CD155) in Breast Cancer Associated with Prognostic Significance and Exhausted Tumor-Infiltrating Lymphocytes: A Cohort Study

Figure 2

Distribution of percentage of tumor cells overexpressing CD155 between molecular subtypes of breast cancer.